FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955692762> ?p ?o ?g. }

• W2955692762 endingPage "882" @default.
• W2955692762 startingPage "882" @default.
• W2955692762 abstract "Abstract Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and third leading cause of cancer deaths worldwide due to late symptom presentation and ineffective treatments. Currently, tyrosine kinase inhibitors Sorafenib and Lenvatinib are the only FDA-approved first-line treatment for HCC patients. Cancer cells experience distinctly high amount of oxidative stress compared to normal cells. Reactive oxygen species (ROS) are by-products of metabolism. However, cancer cells’ metabolic activities are hyper-activated as they have greater demands for energy, thereby also resulting in greater amounts of ROS generated. Besides, oncogenes and properties of the tumor microenvironment like ER stress and hypoxia also contribute to ROS generation in cancer cells. With higher concentrations of ROS, cancer cells also have increased antioxidant production capacity to counteract ROS. NADPH is a major metabolite and antioxidant immensely generated by cancer cells. In human HCC, our group previously found the pentose phosphate pathway and folate cycle to be major metabolic pathways of NADPH production. The thioredoxin system is a ubiquitous mammalian antioxidant system that is activated by the antioxidant system-activating electron donor NADPH. Thioredoxin reductase 1 (TXNRD1) is the sole activating-enzyme of the thioredoxin system through transmission of electron from NADPH to TXN, the ROS-scavenging member of the thioredoxin system. TXNRD1 is imperative for maintenance of intracellular redox homeostasis as confirmed when NRF2 was found to be the transcription activator of TXNRD1. Overexpression of TXNRD1 was found in human HCC with significant correlations with poor clinical prognosis and patient survival. Altogether, these findings are indicative of redox balance being vital for HCC growth. Loss-of-function studies utilizing shRNA-mediated inhibition of TXNRD1 resulted in significant induction of oxidative stress which suppressed HCC growth. The resulting oxidative stress also sensitized HCC cells towards its conventional therapeutic Sorafenib. Translationally, pharmacological TXNRD1 inhibitor auranofin (AUR) also induced oxidative stress which greatly sensitized HCC cells towards Sorafenib. Synergism between AUR and Sorafenib was observed as oxidative stress accumulations dramatically induced apoptosis in vitro and suppressed tumor formation in vivo. Our investigation demonstrated oxidative stress induction through inhibition of the thioredoxin system sensitized HCC cells towards conventional therapeutics. Combination of TXNRD1 inhibitor AUR and Sorafenib represents a novel treatment regimen, with enhanced efficacy, for HCC patients. Citation Format: Derek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, Robin Kit-Ho Lai, Chun-Ming Wong, Irene Oi-Lin Ng, Carmen Chak-Lui Wong. Thioredoxin system inhibition using auranofin represents a new therapeutic approach for hepatocellular carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 882." @default.
• W2955692762 created "2019-07-12" @default.
• W2955692762 creator A5017251689 @default.
• W2955692762 creator A5046165130 @default.
• W2955692762 creator A5061945515 @default.
• W2955692762 creator A5062743704 @default.
• W2955692762 creator A5068409200 @default.
• W2955692762 creator A5083251890 @default.
• W2955692762 date "2019-07-01" @default.
• W2955692762 modified "2023-10-18" @default.
• W2955692762 title "Abstract 882: Thioredoxin system inhibition using auranofin represents a new therapeutic approach for hepatocellular carcinoma" @default.
• W2955692762 doi "https://doi.org/10.1158/1538-7445.am2019-882" @default.
• W2955692762 hasPublicationYear "2019" @default.
• W2955692762 type Work @default.
• W2955692762 sameAs 2955692762 @default.
• W2955692762 citedByCount "0" @default.
• W2955692762 crossrefType "journal-article" @default.
• W2955692762 hasAuthorship W2955692762A5017251689 @default.
• W2955692762 hasAuthorship W2955692762A5046165130 @default.
• W2955692762 hasAuthorship W2955692762A5061945515 @default.
• W2955692762 hasAuthorship W2955692762A5062743704 @default.
• W2955692762 hasAuthorship W2955692762A5068409200 @default.
• W2955692762 hasAuthorship W2955692762A5083251890 @default.
• W2955692762 hasConcept C121608353 @default.
• W2955692762 hasConcept C126322002 @default.
• W2955692762 hasConcept C185592680 @default.
• W2955692762 hasConcept C203014093 @default.
• W2955692762 hasConcept C2776151105 @default.
• W2955692762 hasConcept C2776243873 @default.
• W2955692762 hasConcept C2777575956 @default.
• W2955692762 hasConcept C2777737464 @default.
• W2955692762 hasConcept C2778004101 @default.
• W2955692762 hasConcept C2778019345 @default.
• W2955692762 hasConcept C2778695046 @default.
• W2955692762 hasConcept C3623737 @default.
• W2955692762 hasConcept C48349386 @default.
• W2955692762 hasConcept C502942594 @default.
• W2955692762 hasConcept C55493867 @default.
• W2955692762 hasConcept C71924100 @default.
• W2955692762 hasConcept C86803240 @default.
• W2955692762 hasConcept C96232424 @default.
• W2955692762 hasConcept C98274493 @default.
• W2955692762 hasConceptScore W2955692762C121608353 @default.
• W2955692762 hasConceptScore W2955692762C126322002 @default.
• W2955692762 hasConceptScore W2955692762C185592680 @default.
• W2955692762 hasConceptScore W2955692762C203014093 @default.
• W2955692762 hasConceptScore W2955692762C2776151105 @default.
• W2955692762 hasConceptScore W2955692762C2776243873 @default.
• W2955692762 hasConceptScore W2955692762C2777575956 @default.
• W2955692762 hasConceptScore W2955692762C2777737464 @default.
• W2955692762 hasConceptScore W2955692762C2778004101 @default.
• W2955692762 hasConceptScore W2955692762C2778019345 @default.
• W2955692762 hasConceptScore W2955692762C2778695046 @default.
• W2955692762 hasConceptScore W2955692762C3623737 @default.
• W2955692762 hasConceptScore W2955692762C48349386 @default.
• W2955692762 hasConceptScore W2955692762C502942594 @default.
• W2955692762 hasConceptScore W2955692762C55493867 @default.
• W2955692762 hasConceptScore W2955692762C71924100 @default.
• W2955692762 hasConceptScore W2955692762C86803240 @default.
• W2955692762 hasConceptScore W2955692762C96232424 @default.
• W2955692762 hasConceptScore W2955692762C98274493 @default.
• W2955692762 hasIssue "13_Supplement" @default.
• W2955692762 hasLocation W29556927621 @default.
• W2955692762 hasOpenAccess W2955692762 @default.
• W2955692762 hasPrimaryLocation W29556927621 @default.
• W2955692762 hasRelatedWork W1555681955 @default.
• W2955692762 hasRelatedWork W1563719675 @default.
• W2955692762 hasRelatedWork W1575176480 @default.
• W2955692762 hasRelatedWork W1966597938 @default.
• W2955692762 hasRelatedWork W2142461351 @default.
• W2955692762 hasRelatedWork W2342092661 @default.
• W2955692762 hasRelatedWork W2512076506 @default.
• W2955692762 hasRelatedWork W2593385553 @default.
• W2955692762 hasRelatedWork W2616074690 @default.
• W2955692762 hasRelatedWork W2724471499 @default.
• W2955692762 hasVolume "79" @default.
• W2955692762 isParatext "false" @default.
• W2955692762 isRetracted "false" @default.
• W2955692762 magId "2955692762" @default.
• W2955692762 workType "article" @default.